Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4633-4640

  Maas, Monique ^a   Beets Tan, Regina G H ^a   Lambregts, Doenja M J ^a   Lammering, Guido ^c   Nelemans, Patty J ^b   Engelen, Sanne M E ^a   Van Dam, Ronald M ^a   Jansen, Rob L H ^a   Sosef, Meindert ^d   Leijtens, Jeroen W A ^e   Hulsewé, Karel W E ^d   Buijsen, Jeroen ^c   Beets, Geerard L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRO CLINIC   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; OXALIPLATIN;

ABDOMINAL ABSCESS; ADJUVANT THERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOSCOPY; FEASIBILITY STUDY; FEMALE; FISTULA; FOLLOW UP; HEALTH CARE POLICY; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM BIOPSY; RECTUM CANCER; RESPIRATORY FAILURE; SALVAGE THERAPY; TREATMENT RESPONSE; URINE RETENTION; WOUND INFECTION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; COHORT STUDIES; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVATION; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 83355166959     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.7176     Document Type: Article

References (24)

1. Maas M, Nelemans PJ, Valentini V, et al: Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data. Lancet Oncol 11:835-844, 2010
2. Habr-Gama A, Perez RO, Nadalin W, et al: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg 240:711-717, 2004; discussion 717-718
3. Habr-Gama A, Perez RO, Proscurshim I, et al: Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10: 1319-1328, 2006; discussion 1328-1329
4. Glynne-Jones R, Wallace M, Livingstone JI, et al: Complete clinical response after preoperative chemoradiation in rectal cancer: Is a "wait and see" policy justified? Dis Colon Rectum 51:10-19, 2008; discussion 19-20
5. O'Neill BD, Brown G, Heald RJ, et al: Nonoperative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 8:625-633, 2007 (Pubitemid 47008889)
6. Lahaye MJ, Beets GL, Engelen SM, et al: Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy - Part II. What are the criteria to predict involved lymph nodes? Radiology 252:81-91, 2009
7. Lambregts DM, Beets GL, Maas M, et al: Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer. Ann Surg 253:539-545, 2011
8. Lambregts DM, Vandecaveye V, Barbaro B, et al: Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: A multicenter study. Ann Surg Oncol 18:2224-2231, 2011
9. Engelen SM, Beets-Tan RG, Lahaye MJ, et al: MRI after chemoradiotherapy of rectal cancer: A useful tool to select patients for local excision. Dis Colon Rectum 53:979-986, 2010
10. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213, 2004 (Pubitemid 38963009)
11. Temple LK, Bacik J, Savatta SG, et al: The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 48:1353-1365, 2005 (Pubitemid 40933862)
12. Oliveira L, Pfeifer J, Wexner SD: Physiological and clinical outcome of anterior sphincteroplasty. Br J Surg 83:502-505, 1996 (Pubitemid 26120773)
13. Wang Y, Cummings B, Catton P, et al: Primary radical external beam radiotherapy of rectal adenocarcinoma: Long term outcome of 271 patients. Radiother Oncol 77:126-132, 2005 (Pubitemid 41682376)
14. Moore HG, Gittleman AE, Minsky BD, et al: Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47:279-286, 2004 (Pubitemid 38280578)
15. Tulchinsky H, Shmueli E, Figer A, et al: An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15:2661-2667, 2008
16. Borschitz T, Wachtlin D, Möhler M, et al: Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15:712-720, 2008
17. Marks JH, Valsdottir EB, DeNittis A, et al: Transanal endoscopic microsurgery for the treatment of rectal cancer: Comparison of wound complication rates with and without neoadjuvant radiation therapy. Surg Endosc 23:1081-1087, 2009
18. Perez RO, Habr-Gama A, São Julião GP, et al: Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum 54:545-551, 2011
19. Pucciarelli S, Del Bianco P, Efficace F, et al: Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: A multicenter prospective observational study. Ann Surg 253:71-77, 2011
20. Rutten HJ, den Dulk M, Lemmens VE, et al: Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9:494-501, 2008 (Pubitemid 351626863)
21. Seierstad T, Hole KH, Saelen E, et al: MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy. Radiother Oncol 93:279-284, 2009
22. Crane CH, Eng C, Feig BW, et al: Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76:824-830, 2010
23. Pinto C, Di Fabio F, Maiello E, et al: Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study). Ann Oncol 10.1093/annonc/mdq782 [epub ahead of print on March 8, 2011]
24. Dresen RC, Beets GL, Rutten HJ, et al: Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy - Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252:71-80, 2009